Celestra Inc.
Develops digital biomarkers for monitoring neurological conditions via smart insoles.
352770 | KO
Overview
Corporate Details
- ISIN(s):
- KR7352770002
- LEI:
- Country:
- South Korea
- Address:
- 울산광역시 울주군 언양읍 유니스트길 50 251동 312호, 울산광역시
- Website:
- https://celestrahealth.com/
- Industry:
- Computer programming activities
Description
Celestra Inc. develops and commercializes digital biomarkers for monitoring neurological conditions. The company's core product is the Celestra Health platform, an FDA-designated Class II medical device that provides quantitative gait analysis for patients in their natural environment. The platform utilizes wearable smart insoles equipped with gyroscopes, accelerometers, and pressure sensors to collect movement data. This data is processed by a cloud-based system using advanced machine learning algorithms to measure over 200 aspects of a patient's gait. The system is designed to detect subtle changes in disease progression for conditions such as Multiple Sclerosis and Parkinson’s Disease earlier than traditional clinical assessments. It offers laboratory-grade accuracy, providing clinicians with actionable insights through a proprietary composite index and enabling pharmaceutical firms to assess drug therapy effectiveness more efficiently.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-28 00:00 |
대표이사변경
|
Korean | 10.9 KB | ||
| 2022-03-18 00:00 |
감사보고서제출
|
Korean | 24.7 KB | ||
| 2022-03-18 00:00 |
사업보고서 (2021.12)
|
Korean | 541.1 KB | ||
| 2022-03-10 00:00 |
주주총회소집공고
|
Korean | 247.1 KB | ||
| 2022-02-25 00:00 |
주주총회소집결의
|
Korean | 8.0 KB | ||
| 2022-02-08 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.0 KB | ||
| 2022-02-07 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.5 KB | ||
| 2021-12-08 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2021-11-30 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2021-11-19 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2021-11-12 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 29.4 KB | ||
| 2021-11-12 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 29.4 KB | ||
| 2021-11-11 00:00 |
분기보고서 (2021.09)
|
Korean | 2.0 MB | ||
| 2021-11-01 00:00 |
기타경영사항(특허권취득)(자율공시)(일부 오믹스 정보를 활용하여 전체 오믹스 정보로 확대 생산하는 장치 및 방법)
|
Korean | 5.8 KB | ||
| 2021-10-26 00:00 |
기타경영사항(특허권취득)(자율공시)(질병 카테코리에 대한 통합 위험도 계산 및 시각화 장치 및 방법)
|
Korean | 5.3 KB |
Automate Your Workflow. Get a real-time feed of all Celestra Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Celestra Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Celestra Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
